3-phenyl-3-methoxypyrrolidine derivatives as modulators of cortical catecholaminergic neurotransmission
    1.
    发明授权
    3-phenyl-3-methoxypyrrolidine derivatives as modulators of cortical catecholaminergic neurotransmission 有权
    3-苯基-3-甲氧基吡咯烷衍生物作为皮质儿茶酚胺能神经传递的调节剂

    公开(公告)号:US08673962B2

    公开(公告)日:2014-03-18

    申请号:US13130438

    申请日:2009-11-24

    IPC分类号: A61K31/40 C07D207/12

    CPC分类号: C07D207/12

    摘要: The present invention relates to novel 3-phenyl-3-methoxy-pyrrolidine derivatives, useful for modulating extracellular levels of catecholamines, dopamine and norepinephrine, in cerebral cortical areas of the mammalian brain, and more specifically for the treatment of central nervous system disorders. In other aspects the invention relates to pharmaceutical compositions comprising the 3-phenyl-3-methoxy-pyrrolidine derivatives of the invention and to the use of these compounds for therapeutic applications.

    摘要翻译: 本发明涉及新颖的3-苯基-3-甲氧基吡咯烷衍生物,其可用于调节哺乳动物脑的大脑皮质区域中的儿茶酚胺,多巴胺和去甲肾上腺素的细胞外水平,更具体地涉及治疗中枢神经系统疾病。 在其他方面,本发明涉及包含本发明的3-苯基-3-甲氧基 - 吡咯烷衍生物的药物组合物以及这些化合物在治疗应用中的用途。

    3-PHENYL-3-METHOXYPYRROLIDINE DERIVATIVES AS MODULATORS OF CORTICAL CATECHOLAMINERGIC NEUROTRANSMISSION
    2.
    发明申请
    3-PHENYL-3-METHOXYPYRROLIDINE DERIVATIVES AS MODULATORS OF CORTICAL CATECHOLAMINERGIC NEUROTRANSMISSION 有权
    3-苯甲基-3-甲氧基吡咯烷酮衍生物作为肌醇六烯酰胺神经递质的调节剂

    公开(公告)号:US20110257241A1

    公开(公告)日:2011-10-20

    申请号:US13130438

    申请日:2009-11-24

    CPC分类号: C07D207/12

    摘要: The present invention relates to novel 3-phenyl-3-methoxy-pyrrolidine derivatives, useful for modulating extracellular levels of catecholamines, dopamine and norepinephrine, in cerebral cortical areas of the mammalian brain, and more specifically for the treatment of central nervous system disorders. In other aspects the invention relates to pharmaceutical compositions comprising the 3-phenyl-3-methoxy-pyrrolidine derivatives of the invention and to the use of these compounds for therapeutic applications.

    摘要翻译: 本发明涉及新颖的3-苯基-3-甲氧基吡咯烷衍生物,其可用于调节哺乳动物脑的大脑皮质区域中的儿茶酚胺,多巴胺和去甲肾上腺素的细胞外水平,更具体地涉及治疗中枢神经系统疾病。 在其他方面,本发明涉及包含本发明的3-苯基-3-甲氧基 - 吡咯烷衍生物的药物组合物以及这些化合物在治疗应用中的用途。

    3-phenyl-azetidine derivatives useful as modulators of cortical catecholaminergic neurotransmission
    4.
    发明授权
    3-phenyl-azetidine derivatives useful as modulators of cortical catecholaminergic neurotransmission 有权
    3-苯基 - 氮杂环丁烷衍生物可用作皮质儿茶酚胺能神经传递的调节剂

    公开(公告)号:US08586572B2

    公开(公告)日:2013-11-19

    申请号:US13130384

    申请日:2009-11-24

    IPC分类号: C07D205/04 A61K31/397

    CPC分类号: C07D205/04

    摘要: The present invention relates to novel 3-phenyl-azetidine derivatives, useful for modulating extracellular levels of catecholamines, dopamine and norepinephrine, in cerebral cortical areas of the mammalian brain, and more specifically for the treatment of central nervous system disorders. In other aspects the invention relates to pharmaceutical compositions comprising the 3-phenyl-azetidine derivatives of the invention and to the use of these compounds for therapeutic applications.

    摘要翻译: 本发明涉及新颖的3-苯基 - 氮杂环丁烷衍生物,其可用于调节哺乳动物脑的脑皮层区域中的儿茶酚胺,多巴胺和去甲肾上腺素的细胞外水平,更具体地涉及治疗中枢神经系统疾病。 在其他方面,本发明涉及包含本发明的3-苯基 - 氮杂环丁烷衍生物的药物组合物以及这些化合物在治疗应用中的用途。